影响腮腺区转移性皮肤鳞状细胞癌的手术因素
回顾性分析145例因腮腺区转移性皮肤鳞状细胞癌行腮腺切除加颈淋巴结清扫的患者,3年总生存率74.5%、疾病特异生存率85.5%、无病生存率64.8%。多因素分析显示免疫状态和淋巴血管侵犯预测总生存、疾病特异生存和无病生存,切缘状态和清扫淋巴结数≥18枚预测总生存和疾病特异生存,辅助治疗预测疾病特异生存(p=0.018)。
要点
- 免疫抑制和淋巴血管侵犯与腮腺转移性皮肤鳞状细胞癌更差的总生存、疾病特异生存和无病生存相关。
- 显微镜下切缘阳性和清扫淋巴结<18枚与更差的总生存和疾病特异生存相关。
- 接受辅助治疗的患者疾病特异生存改善(p=0.018)。
核心结论
- 免疫抑制和淋巴血管侵犯预示腮腺转移性皮肤鳞状细胞癌患者结局更差。
- 显微镜下切缘阳性和清扫淋巴结<18枚与更差的总生存和疾病特异生存相关,接受辅助治疗的患者疾病特异生存改善。
研究设计与样本
- 回顾性系列研究,纳入145例因腮腺区转移性皮肤鳞状细胞癌行腮腺切除加颈淋巴结清扫的患者。
- 分析3年总生存、疾病特异生存和无病生存,多因素分析采用Cox比例风险模型。
主要发现
- 总生存率为74.5%,疾病特异生存率为85.5%,无病生存率为64.8%。
- 多因素分析中,免疫状态预测总生存(HR=3.225)、疾病特异生存(HR=5.119)和无病生存(HR=2.071)。
- 淋巴血管侵犯预测总生存(HR=2.380)、疾病特异生存(HR=5.237)和无病生存(HR=2.595)。
- 切缘状态预测总生存(HR=2.296)和疾病特异生存(HR=2.499)。
- 清扫淋巴结≥18枚预测总生存(HR=0.242)和疾病特异生存(HR=0.255),辅助治疗预测疾病特异生存(p=0.018)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Understanding the impact of surgical treatment on regionally metastatic cutaneous squamous cell carcinoma (cSCC). METHODS: Retrospective series of 145 patients undergoing parotidectomy and neck dissection for regionally metastatic cSCC to the parotid. Overall survival (OS), disease-specific survival (DSS), and disease-free survival (DFS) analyzed over 3 years. Multivariate analysis was completed using Cox proportional hazard models. RESULTS: OS was 74.5%, DSS was 85.5% and DFS was 64.8%. On multivariate analysis, immune status (HR = 3.225[OS], 5.119[DSS], 2.071[DFS]) and lymphovascular invasion (HR = 2.380[OS], 5.237[DSS], 2.595[DFS]) were predictive for OS, DSS, and DFS. Margin status (HR = 2.296[OS], 2.499[DSS]) and ≥18 resected nodes (HR = 0.242[OS], 0.255[DSS]) were predictive of OS and DSS, while adjuvant therapy was predictive of DSS (p = 0.018). CONCLUSIONS: Immunosuppression and lymphovascular invasion portended worse outcomes in patients with metastatic cSCC to the parotid. Microscopically positive margins and <18 nodes resected are associated with worse OS and DSS, while patients receiving adjuvant therapy had improved DSS.
引用
- Rao VM, Feng AL, Deschler DG, et al. Surgical factors affecting regionally metastatic cutaneous squamous cell carcinoma to the parotid gland. Head Neck. 2023. PMID: 36891633. doi:10.1002/hed.27304
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。